share_log

Blonder Tongue Laboratories (NYSE:BDR) Research Coverage Started at StockNews.com

Financial News Live ·  Aug 12, 2022 05:02

StockNews.com initiated coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock.

Blonder Tongue Laboratories Price Performance

The business's fifty day moving average price is $0.35. The stock has a market cap of $4.06 million, a P/E ratio of -4.36 and a beta of 0.55. The company has a current ratio of 1.11, a quick ratio of 0.38 and a debt-to-equity ratio of 0.64. Blonder Tongue Laboratories has a 52 week low of $0.28 and a 52 week high of $1.91.

Get Blonder Tongue Laboratories alerts:

About Blonder Tongue Laboratories

(Get Rating)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.

Featured Stories

  • Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
  • Look at Honeywell for a Steady and Diversified Stock
  • Why Invest in High-Yield Dividend Stocks?
  • Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
  • Find and Profitably Trade Stocks at 52-Week Lows
  • Solar Stocks Shine Brightly After Passage Of Clean Energy Bill

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment